 |
Corporate News
12-Sep-23
|
|
|
|
|
|
|
|
|
|
|
|
Life Insurance Corporation dilutes its stake in Dr Reddy's Laboratories
|
|
|
|
|
|
|
|
Life Insurance Corporation of India announced that Corporation's shareholding in "DR REDDY'S LABORATORIES” has diluted from 1,61,44,983 to 1,27,20,873 equity shares, decreasing its shareholding from 9.681% to 7.628% of the paid-up capital of the said Company.
|
|
|
|
Previous News |
Dr. Reddy's launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7%
(
Corporate News
-
14-Jan-26
18:07
)
|
|
|
Dr Reddy’s Swiss subsidiary gets USFDA CRL for biosimilar AVT03
(
Hot Pursuit
-
01-Jan-26
11:57
)
|
|
|
Dr Reddys Laboratories to announce Quarterly Result
(
Corporate News
-
24-Dec-25
10:40
)
|
|
|
Dr Reddys Laboratories allots 9,165 equity shares under ESOS
(
Corporate News
-
09-Dec-25
17:27
)
|
|
|
Dr Reddy’s Lab arm inks pact with Immutep SAS for novel cancer immunotherapy
(
Hot Pursuit
-
08-Dec-25
15:24
)
|
|
|
Dr Reddys Laboratories Ltd up for five straight sessions
(
Hot Pursuit
-
01-Dec-25
13:00
)
|
|
|
Dr Reddys Lab gains after securing EC nod for AVT03
(
Hot Pursuit
-
25-Nov-25
09:50
)
|
|
|
Dr. Reddy's receives EC marketing authorization for AVT03 (denosumab)
(
Corporate News
-
24-Nov-25
17:34
)
|
|
|
Dr Reddys Laboratories Ltd up for fifth session
(
Hot Pursuit
-
17-Nov-25
13:00
)
|
|
|
Dr Reddys Laboratories allots 7,430 equity shares under ESOS
(
Corporate News
-
13-Nov-25
14:59
)
|
|
|
Dr Reddys announces change in senior management
(
Corporate News
-
10-Nov-25
19:00
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|